BioSpace News Archive

Tandem Diabetes Care, Inc. announced that it will make any new features approved for the t:slim X2 Insulin Pump by the FDA in 2018 available to all in-warranty users at no cost through the Tandem Device Updater.

The use of metabolomic constellations instead of individual biomarkers is becoming more and more the focus of in-vitro diagnostics in order to provide information to the treating physicians for diagnostic questions which have not yet been clarified.

AirXpanders, Inc., a medical device company focused on the design, manufacture, sale and distribution of the AeroForm Tissue Expander System, today released its Appendix 4C - Quarterly Cash Flow report for the quarter ended 30 September 2017.

Apollo Endosurgery announced today it has entered into a Registry Funding Agreement with the American Gastroenterological Association (AGA) Center for GI Innovation and Technology to develop and administer a registry to evaluate flexible endoscopic procedures enabled by the OverStitch™ Endoscopic Suturing System.

Bayer announced today that data from its pulmonary disease franchise will be presented in scientific sessions at the 2017 annual meeting of the American College of Chest Physicians (CHEST 2017), October 28 - November 1 in Toronto, Canada.

Tissue Regenix Group plc, the UK based regenerative medical devices company announces subsidiary CellRight Technologies will be participating in The North American Spine Society annual meeting - NASS 2017, being held in Orlando, Florida, October 25-28 2017.

Data Conversion Laboratory (DCL) is offering a free webinar on October 26 at 1:00pm ET to explain the new FDA drug listing rules, which will be affecting all U.S. drug listings.

METTLER TOLEDO is pleased to announce the launch of its brand-new, fully certified InMotion KF Oven Autosamplers: InMotion Flex and InMotion Pro.

BerGenBio announces that the first patient has been dosed in a Phase II trial evaluating the Company’s lead product BGB324 in combination with KEYTRUDA (pembrolizumab).

Ligand Pharmaceuticals Incorporated announced today that it plans to report third quarter 2017 financial results after market close on November 9, 2017 and to provide additional commentary during its Analyst Day.